Australia’s COVID-19 vaccination program underwent a major
structural change on 1 October 2026. COVID-19 vaccines are now funded under the
National Immunisation Program (NIP) instead of the previous stand-alone
National COVID-19 Vaccine Program.1
The National COVID-19 Vaccine Program was established as part of Australia’s emergency
response to the COVID-19 pandemic to support broad access to vaccination when most
of the population lacked immunity to the disease.2
COVID-19 is now endemic in Australia and continues to disproportionately affect
certain populations.3
Under the new model, COVID-19 vaccination will no longer be
universally funded. Instead, free COVID-19 vaccines will be available only for the
following groups at highest risk of severe disease:4
-
adults aged 75 years and over (one dose every 6 months)
-
adults aged 65 to 74 years (one dose every 12 months)
-
Aboriginal and Torres Strait Islander people aged 50 to 74 years
(one dose every 12 months)
-
adults aged 18 years and over with severe immunocompromise
(one dose every 12 months).
This approach aligns COVID-19 vaccination with the funding arrangements
for other NIP vaccines, supporting sustainable program delivery while
maintaining protection in vulnerable populations.
People who do not meet the NIP eligibility criteria can still choose
to purchase the vaccine privately, following consultation with their healthcare
provider.
Since 1 October 2026, under the NIP, states and territories
have assumed responsibility for vaccine ordering, distribution and reporting
processes, consistent with arrangements for other NIP-funded vaccines.4
Healthcare providers should refer to support materials and the
latest information from the Department of Health when updating processes for vaccine
ordering, reporting and assessing patient eligibility. The Australian
Immunisation Handbook remains a primary resource for current recommendations
and guidance on vaccine administration, storage and handling.5
Australian Prescriber welcomes Feedback.